EURONET WORLDWIDE, INC. (EEFT) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.39%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.39% | Share-based compensation / revenue. Period ending 2026-06-30. $60.60M ÷ $4.37B × 100 ≈ 1.39% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 4.37B USD | |
| Stock-based compensation | 60.60M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 505.10M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.37B | $60.60M | $505.10M | (m) | (m) | 1.39% | (m) | (m) |
| 2026-03-31 | (m) | $4.34B | $58.70M | $526.60M | (m) | (m) | 1.35% | (m) | (m) |
| 2025-12-31 | (m) | $4.24B | $55.10M | $529.80M | (m) | (m) | 1.30% | (m) | (m) |
| 2025-09-30 | (m) | $4.18B | $50.40M | $551.50M | (m) | (m) | 1.20% | (m) | (m) |
| 2025-06-30 | (m) | $4.14B | $46.20M | $538.70M | (m) | (m) | 1.12% | (m) | (m) |
| 2025-03-31 | (m) | $4.05B | $42.60M | $514.40M | (m) | (m) | 1.05% | (m) | (m) |
| 2024-12-31 | (m) | $3.99B | $43.90M | $503.20M | (m) | (m) | 1.10% | (m) | (m) |
| 2024-09-30 | (m) | $3.90B | $47.50M | $477.90M | (m) | (m) | 1.22% | (m) | (m) |
| 2024-06-30 | (m) | $3.80B | $49.60M | $462.70M | (m) | (m) | 1.30% | (m) | (m) |
| 2024-03-31 | (m) | $3.76B | $51.90M | $451.00M | $60.40M | (m) | 1.38% | 7.47× | Reported |
| 2023-12-31 | (m) | $3.69B | $53.70M | $432.60M | $55.60M | (m) | 1.46% | 7.78× | Reported |
| 2023-09-30 | (m) | $3.60B | $53.30M | $414.24M | $50.09M | (m) | 1.48% | 8.27× | Reported |
| 2023-06-30 | (m) | $3.52B | $51.00M | $415.74M | $46.78M | (m) | 1.45% | 8.89× | Reported |
| 2023-03-31 | (m) | $3.43B | $48.60M | $394.24M | $41.59M | (m) | 1.42% | 9.48× | Reported |
| 2022-12-31 | (m) | $3.36B | $44.10M | $385.34M | $37.59M | (m) | 1.31% | 10.25× | Reported |
| 2022-09-30 | (m) | $3.30B | $40.54M | $335.19M | $36.19M | (m) | 1.23% | 9.26× | Reported |
| 2022-06-30 | (m) | $3.19B | $37.01M | $281.23M | $34.55M | (m) | 1.16% | 8.14× | Reported |
| 2022-03-31 | (m) | $3.06B | $37.85M | $210.27M | $35.14M | (m) | 1.24% | 5.98× | Reported |
| 2021-12-31 | (m) | $3.00B | $36.54M | $184.02M | $38.20M | (m) | 1.22% | 4.82× | Reported |
| 2021-09-30 | (m) | $2.89B | $33.73M | $205.28M | $37.73M | (m) | 1.17% | 5.44× | Reported |
| 2021-06-30 | (m) | $2.74B | $31.96M | $156.86M | $37.13M | (m) | 1.17% | 4.22× | Reported |
| 2021-03-31 | (m) | $2.55B | $24.11M | $25.47M | $36.56M | (m) | 0.94% | 0.70× | Reported |
| 2020-12-31 | (m) | $2.48B | $21.95M | $46.62M | $36.60M | (m) | 0.88% | 1.27× | Reported |
| 2020-09-30 | (m) | $2.47B | $19.99M | $103.62M | $36.51M | (m) | 0.81% | 2.84× | Reported |
| 2020-06-30 | (m) | $2.59B | $20.41M | $231.53M | $36.13M | (m) | 0.79% | 6.41× | Reported |
| 2020-03-31 | (m) | $2.76B | $23.29M | $450.70M | $37.27M | (m) | 0.84% | 12.09× | Reported |
| 2019-12-31 | (m) | $2.75B | $21.44M | $475.19M | $36.24M | (m) | 0.78% | 13.11× | Reported |
| 2019-09-30 | (m) | $2.71B | $20.12M | $439.14M | $35.96M | (m) | 0.74% | 12.21× | Reported |
| 2019-06-30 | (m) | $2.63B | $18.68M | $396.06M | $38.13M | (m) | 0.71% | 10.39× | Reported |
| 2019-03-31 | (m) | $2.56B | $17.23M | $368.54M | $38.17M | (m) | 0.67% | 9.66× | Reported |
| 2018-12-31 | (m) | $2.54B | $16.76M | $357.91M | $37.57M | (m) | 0.66% | 9.53× | Reported |
| 2018-09-30 | (m) | $2.49B | $16.40M | $327.87M | $36.45M | (m) | 0.66% | 9.00× | Reported |
| 2018-06-30 | (m) | $2.42B | $16.11M | $293.86M | $34.71M | (m) | 0.67% | 8.47× | Reported |
| 2018-03-31 | (m) | $2.33B | $15.94M | $270.18M | $33.03M | (m) | 0.68% | 8.18× | Reported |
| 2017-12-31 | (m) | $2.25B | $15.62M | $266.00M | $32.57M | (m) | 0.69% | 8.17× | Reported |
| 2017-09-30 | (m) | $2.17B | $15.45M | $282.98M | $32.42M | (m) | 0.71% | 8.73× | Reported |
| 2017-06-30 | (m) | $2.05B | $15.27M | $256.55M | $30.61M | (m) | 0.74% | 8.38× | Reported |
| 2017-03-31 | (m) | $1.99B | $14.98M | $249.17M | $29.19M | (m) | 0.75% | 8.53× | Reported |
| 2016-12-31 | (m) | $1.96B | $14.98M | $249.77M | $28.33M | (m) | 0.76% | 8.82× | Reported |
| 2016-09-30 | (m) | $1.91B | $14.89M | $246.89M | $27.30M | (m) | 0.78% | 9.04× | Reported |
| 2016-06-30 | (m) | $1.87B | $14.20M | $226.70M | $26.27M | (m) | 0.76% | 8.63× | Reported |
| 2016-03-31 | (m) | $1.81B | $13.64M | $214.57M | $25.40M | (m) | 0.75% | 8.45× | Reported |
| 2015-12-31 | (m) | $1.77B | $12.80M | $204.84M | $24.81M | (m) | 0.72% | 8.26× | Reported |
| 2015-09-30 | (m) | $1.76B | $12.54M | $199.11M | $23.34M | (m) | 0.71% | 8.53× | Reported |
| 2015-06-30 | (m) | $1.74B | $12.81M | $179.56M | $19.69M | (m) | 0.74% | 9.12× | Reported |
| 2015-03-31 | (m) | $1.71B | $12.64M | $166.51M | $16.04M | (m) | 0.74% | 10.38× | Reported |
| 2014-12-31 | (m) | $1.66B | $12.90M | $158.73M | $12.33M | (m) | 0.78% | 12.87× | Reported |
| 2014-09-30 | (m) | $1.58B | $12.08M | $125.35M | $9.24M | (m) | 0.77% | 13.56× | Reported |
| 2014-06-30 | (m) | $1.48B | $11.82M | $129.96M | $9.13M | (m) | 0.80% | 14.23× | Reported |
| 2014-03-31 | (m) | $1.43B | $12.10M | $123.64M | $9.27M | (m) | 0.85% | 13.34× | Reported |
| 2013-12-31 | (m) | $1.41B | $11.46M | $118.41M | $10.14M | (m) | 0.81% | 11.68× | Reported |
| 2013-09-30 | (m) | $1.39B | $12.02M | $100.42M | $11.48M | (m) | 0.87% | 8.74× | Reported |
| 2013-06-30 | (m) | $1.34B | $11.35M | $69.27M | $14.03M | (m) | 0.84% | 4.94× | Reported |
| 2013-03-31 | (m) | $1.31B | $10.65M | $61.32M | $17.03M | (m) | 0.82% | 3.60× | Reported |
| 2012-12-31 | (m) | $1.27B | $11.82M | $58.01M | $19.65M | (m) | 0.93% | 2.95× | Reported |
| 2012-09-30 | (m) | $1.24B | $11.61M | $82.89M | $22.24M | (m) | 0.94% | 3.73× | Reported |
| 2012-06-30 | (m) | $1.22B | $12.14M | $78.82M | $21.94M | (m) | 1.00% | 3.59× | Reported |
| 2012-03-31 | (m) | $1.20B | $12.97M | $77.76M | $21.53M | (m) | 1.08% | 3.61× | Reported |
| 2011-12-31 | (m) | $1.16B | $10.76M | $79.14M | $21.39M | (m) | 0.93% | 3.70× | Reported |
| 2011-09-30 | (m) | $1.13B | $10.59M | $6.38M | $21.07M | (m) | 0.94% | 0.30× | Reported |
| 2011-06-30 | (m) | $1.09B | $10.15M | $6.51M | $20.97M | (m) | 0.93% | 0.31× | Reported |
| 2011-03-31 | (m) | $1.05B | $8.82M | $4.26M | $20.83M | (m) | 0.84% | 0.20× | Reported |
| 2010-12-31 | (m) | $1.04B | $9.29M | $5.27M | $20.45M | (m) | 0.90% | 0.26× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.03B | $7.93M | $72.27M | $25.72M | (m) | 0.77% | 2.81× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.05B | $8.55M | $-149.02M | $36.35M | (m) | 0.82% | -4.10× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LESAKA TECHNOLOGIES INC (LSAK) | $0.357B | ||
| Usio, Inc. (USIO) | United States | $0.065B |